BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial
COVID-19에 대한 타고난 면역 반응을 개선하기 위해 브라질에서 의료 종사자의 BCG 재접종: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] accompany
activate
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus-2
Admission
Antibiotics
antiviral immune response
approved
assigned
Autoimmune
Autoimmune diseases
Bacillus
BCG
BCG revaccination
BCG vaccination
bcg vaccine
blinded
Blinding
block
blocks
both groups
Brazil
Breastfeeding
carried
CFU
Characteristics
Chemotherapy
childhood
city
clinical trial
Committee
Comorbidities
Comorbidity
confirmation
Contact
contact with
control group
Coronavirus-2
COVID-19
COVID-19 patient
COVID-19 severity
COVID-19 symptoms
COVID-19 test
cross-protection
determined by
diagnosed
direct contact
disease
disease severity
Diseases
dissemination
dose
doses
Effectiveness
element
elicited
eligibility criteria
Fever
health worker
health workers
healthcare providers
HIV
hospital
Hypothesis
ICU
identification number
IgG and IgM
IgM and IgG
IgM test
immunosuppressive
IMPROVE
in both group
incidence
incidence of COVID-19
Inclusion
inclusion criteria
India
induce
Infection
infections
information
innate immune response
investigator
Laboratory
lateral flow
less
macrophages
medication
meet
memory
monocyte
Monocytes
Mortality
naso-oropharyngeal swab
neutrophil
Neutrophils
NK
NK cell
number
Nurses
objective
Open-label
outcome
outcomes
pandemic
parallel-group
participant
physiotherapists
platform
presenting
Prevent
Primary outcome
Primary outcomes
professional
protocol
randomisation
randomised
randomised controlled trial
randomization
Randomized
receive
recruit
recruitment
reduce
Registered
registration number
researcher
researchers
respiratory
revaccination
right arm
RT-PCR
Sample size
SARS-CoV-2
scar
sealed
Secondary objective
Secondary objectives
secondary outcome
severe acute respiratory syndrome Coronavirus
severity
solid tumour
specimen
statistical analyses
status
steroid
Study protocol
Symptom
symptomatic infection
the disease
the vaccine
Trial
Trial registration
Tuberculosis
two groups
vaccination
Vaccine
virus
virus infection
virus infections
was performed
website
WHO
[DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter